New England Biolabs Offers Development Tools for a New Generation of Laboratory Tests
New England Biolabs is improving accessibility with a range of development tools, including shelf-stable reagents and enzyme-based tools.
Read MorePosted by Chris Wolski | Oct 30, 2024 | Immunoassay |
New England Biolabs is improving accessibility with a range of development tools, including shelf-stable reagents and enzyme-based tools.
Read MorePosted by Chris Wolski | Oct 29, 2024 | Sepsis |
A genetic signature in newborns can predict neonatal sepsis before symptoms appear, according to a new study by UBC and SFU researchers.
Read MorePosted by Andy Lundin | Oct 24, 2024 | Molecular Diagnostics |
Early results from a new study demonstrate that genomic sequencing identifies significantly more treatable health conditions in newborns.
Read MorePosted by Andy Lundin | Oct 22, 2024 | Molecular Diagnostics, Swabs |
OralDNA Labs acquired Sensible Diagnostics to enhance its rapid point-of-care molecular diagnostic testing capabilities.
Read MorePosted by Chris Wolski | Oct 11, 2024 | Molecular Diagnostic Analyzers |
Two case studies illustrate how a newly developed sepsis test improves turnaround times and diagnostic accuracy.
Read More